Skip to content

FP7H2020HORIZON

Institute of Cancer Research: the Royal Cancer Hospital LBG

Country
GBUnited Kingdom
Defence projects
0
Projects, all programmes
39
As coordinator
17
EU contribution (CORDIS)
EUR 13,381,671
Active
2008 to 2026

Projects

39 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
TAMIRCRTTargeting microRNAs for ColoRectal Cancer TherapyFP72013CoordinatorEUR 9,341
ICRMYELOMASequence of Mutational Events and Sub-clonal Architecture in Plasma Cell MyelomaFP72012CoordinatorEUR 209,033
CTCTRAPCirculating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patientsFP72012ParticipantEUR 636,250
CELARCELAR: Automatic, multi-grained elasticity-provisioning for the CloudFP72012ParticipantEUR 5,898
SYSCOLSystems Biology of Colorectal CancerFP72011ParticipantEUR 853,028
DDRESPONSEThe DNA damage response and breast cancerFP72011ParticipantEUR 685,867
Melanoma InvasionMolecular mechanisms of melanoma invasionFP72011CoordinatorEUR 209,593
pARylomepARylation-mediated regulation of cancer pathwaysFP72011CoordinatorEUR 30,000
EUROCANPLATFORMA European Platform for Translational Cancer ResearchFP72011ParticipantEUR 225,600
QUIC-CONCEPTQUantitative Imaging in Cancer: CONnecting CEllular Processes with TherapyFP72011ParticipantEUR 560,800
ECNIS2ECNIS2: towards ECNIS Centre for Research and Education on Cancer, Environment and FoodFP72011ParticipantNot stated
BASISBreast Cancer Somatic Genetics StudyFP72010ParticipantEUR 90,716
SAGHESafety and Appropriateness of Growth hormone treatments in EuropeFP72009ParticipantEUR 151,751
HER2 MAMMARYSTEMCELLThe influence of Her2 status on mammary stem/progenitor cellsFP72009CoordinatorEUR 171,868
COGSCollaborative Oncological Gene-environment StudyFP72009ParticipantEUR 600,675
EPOCEuropean Paediatric Oncology Off-Patent Medicines ConsortiumFP72009ParticipantNot stated
SYNTHLE BRCASynthetic lethality approaches to BRCA-associated cancerFP72008CoordinatorEUR 169,391
BASAL BREAST CANCERCharacterization of myoepithelial differentiation in basal-like breast cancer cellsFP72008CoordinatorEUR 169,391
03KOral Off-patent Oncology Drugs for KidsFP72008ParticipantEUR 54,178

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.